Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment.


Journal

Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208

Informations de publication

Date de publication:
06 Sep 2023
Historique:
received: 19 07 2023
revised: 22 08 2023
accepted: 30 08 2023
medline: 4 10 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Paroxysmal nocturnal hemoglobinuria (PNH) is a nonmalignant clonal hematopoietic disorder characterized by the lack of glycosylphosphatidylinositol-anchored proteins (GPI-APs) as a consequence of somatic mutations in the phosphatidylinositol glycan anchor biosynthesis class A (

Identifiants

pubmed: 37763731
pii: medicina59091612
doi: 10.3390/medicina59091612
pmc: PMC10535188
pii:
doi:

Substances chimiques

Complement System Proteins 9007-36-7
Glycosylphosphatidylinositols 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : AA&MDS International Foundation
ID : AAMDS1807VV

Références

N Engl J Med. 2015 Sep 10;373(11):1032-9
pubmed: 26352814
Br J Haematol. 2005 Feb;128(4):571-7
pubmed: 15686469
Blood Adv. 2017 Oct 10;1(22):1900-1910
pubmed: 28971166
Rinsho Ketsueki. 2008 Jul;49(7):498-504
pubmed: 18709982
Blood. 2006 Feb 1;107(3):1184-91
pubmed: 16195329
Front Immunol. 2022 Jan 28;12:830172
pubmed: 35154088
Br J Haematol. 2003 Nov;123(3):545-51
pubmed: 14617023
Haematologica. 2012 Nov;97(11):1666-73
pubmed: 22689687
J Leukoc Biol. 2002 Dec;72(6):1228-33
pubmed: 12488505
Eur J Immunol. 1995 Jul;25(7):1815-22
pubmed: 7542590
Br J Haematol. 1997 Jan;96(1):92-7
pubmed: 9012693
N Engl J Med. 1991 Oct 3;325(14):991-6
pubmed: 1886636
Front Immunol. 2021 Dec 24;12:777649
pubmed: 35003092
Hum Immunol. 2008 Mar;69(3):202-6
pubmed: 18396213
Curr Opin Hematol. 2001 Jan;8(1):5-11
pubmed: 11138627
N Engl J Med. 2022 Jan 6;386(1):11-23
pubmed: 34986284
Pediatr Blood Cancer. 2014 Sep;61(9):1544-50
pubmed: 24777716
Leukemia. 2005 May;19(5):862-8
pubmed: 15759038
Blood. 2000 Jan 15;95(2):646-50
pubmed: 10627475
Blood. 2005 May 15;105(10):3848-54
pubmed: 15687243
Mol Genet Metab. 2003 Apr;78(4):291-4
pubmed: 12706380
Leukemia. 2011 Feb;25(2):379-82
pubmed: 21116280
Blood. 2011 Jun 23;117(25):6786-92
pubmed: 21460245
Exp Hematol. 2002 Jul;30(7):774-82
pubmed: 12135676
Exp Hematol. 2009 Jan;37(1):42-51
pubmed: 19013003
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18496-500
pubmed: 19011109
Blood. 1998 Oct 1;92(7):2541-50
pubmed: 9746796
Lancet. 2007 Apr 21;369(9570):1379-1390
pubmed: 17448825
Cancer Genet. 2015 Apr;208(4):115-28
pubmed: 25800665
Transplant Proc. 2010 Oct;42(8):3266-70
pubmed: 20970669
Rheumatology (Oxford). 2020 Oct 1;59(10):2661-2670
pubmed: 32638005
Blood. 2019 Feb 7;133(6):530-539
pubmed: 30510080
N Engl J Med. 2022 Jul 14;387(2):160-166
pubmed: 35830642
Leukemia. 2023 Jan;37(1):202-211
pubmed: 36253429
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8756-60
pubmed: 9238050
J Clin Invest. 2014 Oct;124(10):4529-38
pubmed: 25244093
Blood. 2021 Dec 30;138(26):2799-2809
pubmed: 34724566
Int J Hematol. 2002 Aug;76 Suppl 2:168-72
pubmed: 12430920
Blood. 2002 Dec 1;100(12):4116-22
pubmed: 12393537
PLoS Comput Biol. 2018 Jun 18;14(6):e1006133
pubmed: 29912864
N Engl J Med. 2006 Sep 21;355(12):1233-43
pubmed: 16990386
Blood. 2007 Jun 1;109(11):5036-42
pubmed: 17284529
Cell. 1997 Jan 10;88(1):1-4
pubmed: 9019395
Semin Hematol. 1989 Jul;26(3):201-7
pubmed: 2675316
Br J Haematol. 2004 Jul;126(1):133-8
pubmed: 15198744
Blood. 2009 Apr 23;113(17):4094-100
pubmed: 19179465
Blood. 2020 Mar 19;135(12):912-920
pubmed: 31978221
Oncotarget. 2017 Sep 28;8(54):92411-92419
pubmed: 29190926
N Engl J Med. 2004 Feb 5;350(6):552-9
pubmed: 14762182
Blood Cancer J. 2012 Mar;2(3):e63
pubmed: 22829258
N Engl J Med. 1995 Nov 9;333(19):1253-8
pubmed: 7566002
Blood. 1997 Oct 1;90(7):2716-22
pubmed: 9326238
Exp Hematol. 2002 Mar;30(3):187-94
pubmed: 11882355
Blood. 2002 Aug 1;100(3):1031-7
pubmed: 12130519
N Engl J Med. 2021 Mar 18;384(11):1028-1037
pubmed: 33730455
Nat Biotechnol. 2007 Nov;25(11):1256-64
pubmed: 17989688
Ann Hematol. 2022 Sep;101(9):1971-1986
pubmed: 35869170
Haematologica. 2006 Jun;91(6):856-7
pubmed: 16704965
Blood. 2008 Feb 15;111(4):1840-7
pubmed: 18055865
Indian J Pediatr. 2008 Jun;75(6):575-8
pubmed: 18759084
Blood. 2017 Jan 19;129(3):388-392
pubmed: 27903525
J Clin Lab Anal. 2021 Mar;35(3):e23667
pubmed: 33249661
Blood. 2023 Apr 13;141(15):1812-1816
pubmed: 36626252
Blood. 2002 Jul 1;100(1):22-8
pubmed: 12070003
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5209-14
pubmed: 10220445
Blood. 2001 Dec 15;98(13):3513-9
pubmed: 11739151
Lancet Haematol. 2021 May;8(5):e344-e354
pubmed: 33765419
Arch Immunol Ther Exp (Warsz). 2011 Jun;59(3):231-8
pubmed: 21442308
Semin Immunol. 2023 May;67:101766
pubmed: 37141766
Leukemia. 2016 May;30(5):1208-10
pubmed: 26437783
PLoS One. 2011 Feb 01;6(2):e14643
pubmed: 21408106
Science. 1998 Mar 6;279(5356):1541-4
pubmed: 9488653
Blood. 2019 Feb 7;133(6):540-549
pubmed: 30510079
Adv Ther. 2023 Jan;40(1):211-232
pubmed: 36272026
Blood. 2006 Dec 15;108(13):4232-6
pubmed: 16940417
Hematol Oncol Stem Cell Ther. 2012;5(3):138-45
pubmed: 23095789

Auteurs

Carlos Bravo-Perez (C)

Department of Translational Hematology & Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44114, USA.
Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, IMIB-Pascual Parrilla, CIBERER-Instituto de Salud Carlos III, University of Murcia, 30005 Murcia, Spain.

Luca Guarnera (L)

Department of Translational Hematology & Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44114, USA.
Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.

Nakisha D Williams (ND)

Department of Translational Hematology & Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44114, USA.

Valeria Visconte (V)

Department of Translational Hematology & Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH 44114, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH